Inhibitory effects of melatonin on ferric nitrilotriacetate-induced lipid peroxidation and oxidative DNA damage in the rat kidney

Toxicology

Volumn 139, Issue 1-2, 1999, Pages 81-91

  Qi, Wenbo ^a   Reiter, Russel J ^a   Tan, Dun Xian ^a   Manchester, Lucien C ^a   Kim, Seok Joong ^a   Garcia, Joaquin J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Ferric nitrilotriacetate; Lipid peroxidation; Melatonin; Oxidative DNA damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; MALONALDEHYDE; MELATONIN; NITRILOTRIACETATE IRON; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; IN VITRO STUDY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY HOMOGENATE; KIDNEY INJURY; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARCINOGENS; DEOXYGUANOSINE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRIC COMPOUNDS; FREE RADICAL SCAVENGERS; INDICATORS AND REAGENTS; KIDNEY; LIPID PEROXIDATION; MALE; MELATONIN; NITRILOTRIACETIC ACID; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032718840     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00100-6     Document Type: Article

References (49)

1. Anderson R.L., Bishop W.E., Campbell R.L. A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit. Rev. Toxicol. 15:1985;1-102.
2. Antolin I., Rodriquez C., Sainz R.M., Antolin F., Menendez-Pelaez A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10:1996;882-890.
3. Aruoma O.I., Gaejewski H.E., Dizdaroglu M. Damage to the base in DNA induced by hydrogen peroxide and ferric iron chelates. J. Biol. Chem. 264:1989;20509-20512.
4. Awai M., Narasaki M., Yamanoi Y., Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. Am. J. Pathol. 95:1979;663-672.
5. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M.I., Menendez-Pelaez A., Chen L.D., Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26:1995;497-502.
6. Bradford M. Rapid and sensitive method for quantification of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Cagnoli C.M., Atabay C., Kharlamov E., Manev H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 18:1995;222-228.
8. Carnerio R.C., Reiter R.J. Delta-aminolevulinic acid-induced lipid peroxidation in rat kidney and liver is attenuated by melatonin: an in vitro and in vivo study. J. Pineal Res. 24:1998;131-136.
9. Costa E.J.X., Lopes R.H., Lamy-Freund M.T. Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 16:1994;123-126.
10. Cuzzocrea S., Zingarelli B., Gilad E., Hake P., Salzman A.L., Szabo C. Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J. Pineal Res. 23:1997;106-116.
11. Ebina Y., Okada S., Hamazaki S., Ogino F., Li J., Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complex in rats. J. Natl. Cancer Inst. 76:1986;107-113.
12. Gilad E., Cuzzocrea S., Zingarelli B., Salzman A.L., Szabo C. Melatonin is a scavenger of peroxynitrite. Life Sci. 60:1997;169-174.
13. Guder W.G., Ross B.D. Enzyme distribution along the nephron. Kidney Int. 26:1984;101-111.
14. Hafn R., Wendel A., Flohe L. The fate of extracellular glutathione in the rat. Biochim. Biophys. Acta. 539:1978;324-337.
15. Hamazaki S., Okada S., Ebina Y., Fujioka M., Midorikawa O. Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol. Appl. Pharmacol. 77:1985;267-274.
16. Hamazaki S., Okada S., Toyokuni S., Midorikawa O. Thiobarbituric acid-reactive substance formation of rat kidney brush border membrane vesicles induced by ferric nitrilotriacetate. Arch. Biochem. Biophys. 274:1989a;348-354.
17. Hamazaki S., Okada S., Li J.L., Toyokuni S., Midorikawa O. Oxygen reduction and lipid peroxidation by iron chelates with special reference to FeNTA. Arch. Biochem. Biophys. 272:1989b;10-17.
18. Hardeland R., Reiter R.J., Poeggeler B., Tan D.-X. The significance of the metabolism of the neurohormone melatonin: antioxidant protection and formation of bioactive substances. Neurosci. Biobehav. Res. 17:1993;347.
19. King M., Scaiano J.C. The excited states of melatonin. Photochem. Photobiol. 65:1997;538-542.
20. Kotler M., Rodriquez C., Sainz R.M., Antolin I., Menendez-Pelaez A. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J. Pineal Res. 24:1998;83-89.
21. Li J., Okada S., Hamazaki S., Ebina Y., Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res. 47:1987;1867-1869.
22. Limson J., Nyokong T., Daya S. The interaction of melatonin and its precursors with aluminum, cadmium, copper, iron, lead and zinc: an adsorptive voltammetric study. J. Pineal Res. 24:1998;15-21.
23. Mahal H.S., Sharma H.S., Mukherjee T. Antioxidant properties of melatonin: a pulse radiolysis study. Free Radical Biol. Med. 26:1999;557-565.
24. Melchiorri D., Reiter R.J., Attia A.M., Hara M., Burgos A., Nistico G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:1994;83-89.
25. Montilla P.L., Tunez I.F., Munoz de Agueda C., Gascon F.L., Soria J.V. Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats. J. Pineal Res. 25:1998;86-93.
26. Mottola H.A. Nitrilotriacetic acid as a chelating agent: application, toxicology and bio-environmental impact. Toxicol. Environ. Chem. Rev. 2:1974;99-161.
27. Noda Y., Mori A., Liburdy R., Packer L. Melatonin and its precursors scavenge nitric oxide. J. Pineal Res. 27:1999;159-163.
28. Okada S., Midorikawa O. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn. Arch. Internal Med. 29:1982;485-491.
29. Okada S., Hamazaki S., Ebina Y., Li J.-L., Midorikawa O. Nephrotoxity and its prevention by vitamin E in FeNTA-promoted lipid peroxidation. Biochem. Biophys. Acta. 922:1987;28-33.
30. Pablos M.I., Reiter R.J., Ortiz G.G., Guerrero J.M., Agapito M.T., Chuang J.I., Sewerynek E. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem. Int. (Suppl). 5:1998;61-66.
31. Pieri C., Moroni F., Marra M., Recchioni R., Marcheselli F. Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:1994;271-276.
32. Poeggeler B., Reiter R.J., Hardeland R., Sewerynek E., Melchiorri D., Barlow-Walden L.R. Melatonin-a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidative chemistry of the indole accessed in vitro. Ann. NY Acad. Sci. 738:1994;419-420.
33. Preece N.E., Evans P.E., Howarth J.A., King L.J., Parke D.V. The induction of autooxidative tissue damage by iron nitrilotriacetate in rats and mice. Toxicol. Appl. Pharmacol. 93:1988;89-100.
34. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56:1998;339-384.
35. Reiter R.J., Tan D.-X., Poeggeler B., Menendez-Pelaez A., Chen L.-D., Saarela S. Melatonin as free radical scavenger: implications for aging and age-related diseases. Ann. NY Acad. Sci. 719:1994;1-12.
36. Reiter R.J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L.R., Chuang J.I., Ortiz G.G., Acuna-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1995;1-11.
37. Reiter R.J., Tang L., Garcia J.J., Munoz-Hoyos H. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:1997;2255-2271.
38. Reiter R.J., Tan D.X., Qi W. A brief survey of observations and mechanisms related to suppression of oxygen toxicity by melatonin. Acta Pharmacol Sinica. 19:1998a;575-581.
39. Reiter R.J., Tan D.-X., Kim S.J., Qi W. Melatonin as a pharmacological agent against oxidative damage to lipids and DNA. Proc. West Pharmacol. Soc. 41:1998b;229-236.
40. Shida C.S., Castrucci A.M.L., Lamy-Freund M.T. High melatonin solubility in aqueous medium. J. Pineal Res. 16:1994;198-201.
41. Shigenaga M.K., Aboujaoude E.N., Chen Q., Ames B.N. Assays of oxidative DNA damage biomarkers 8-oxo-2-deoxyguanosione and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 234:1994;16-33.
42. Stasica P., Ulanski P., Rosiak J.M. Melatonin as a hydroxyl radical scavenger. J. Pineal Res. 25:1998;65-66.
43. Susa N., Ueno S., Furukawa Y., Ueda J., Sugiyama M. Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol. 144:1997;377-384.
44. Tan D.-X., Chen L.-D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J. 1:1993;57-60.
45. Tan D.-X., Manchester L.C., Reiter R.J., Plummer B.F., Hardies L.J., Weintraub S.T., Vijayalaxmi, Shepherd A.M.M. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem. Biophys. Res. Commun. 253:1998;614-620.
46. Toyokuni S., Uchida K., Okamoto K., Hattori-Nakakuki Y., Hiai H., Stadtman E.R. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. USA. 91:1994;2616-2620.
47. Tsao B., Curthoys N.P. The absolute asymmetry of orientation of gamma-glutamyltranspeptidase and aminopeptidase on the external surface of the rat renal brush border membrane. J. Biol. Chem. 255:1980;7708-7711.
48. Umemura T.Y., Sai K., Takagi A., Hasegawa R., Kurokawa Y. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis. 11:1990a;345-347.
49. Umemura T.Y., Sai K., Takagi A., Hasegawa R., Kurokawa Y. Oxidative DNA damage, lipid peroxidation and nephrotoxity induced in the rat kidney after ferric nitrilotriacetate administration. Cancer Lett. 54:1990b;95-100.